VEZF1 and cancer: The need for new cancer therapeutics and the necessity to understand the complex mechanisms involved in regulation of cell-type specific genes has increased the demand for comprehensive characterization of small molecule inhibitors against factors such as Vezf1 that can potentially work in a restricted fashion and block angiogenesis and hyper-vascularization in diseased state.